Antibiotic treatment duration for bacteraemic pneumonia
- PMID: 34688364
- DOI: 10.1016/S0140-6736(21)01735-9
Antibiotic treatment duration for bacteraemic pneumonia
Conflict of interest statement
JC reports personal fees from Sanofi. ND reports personal fees from Boehringer Ingelheim and Roche, and non-financial support from Janssen, Merck Sharp and Dohme, and Pfizer.
Comment in
-
Antibiotic treatment duration for bacteraemic pneumonia - Author's reply.Lancet. 2021 Oct 23;398(10310):1485-1486. doi: 10.1016/S0140-6736(21)01732-3. Lancet. 2021. PMID: 34688365 No abstract available.
Comment on
-
Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial.Lancet. 2021 Mar 27;397(10280):1195-1203. doi: 10.1016/S0140-6736(21)00313-5. Lancet. 2021. PMID: 33773631 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical